Clinical Trials · NCT01394341
Liraglutide Treatment to Patients With Severe Renal Insufficiency
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Bo Feldt-Rasmussen
- Enrollment
- 40
- Start date
- Sep 2011
- Locations
- 3 sites, Denmark
- Primary endpoint
- Plasma liraglutide concentration (pmol/L)